Both in Pharmaceuticals
Supernus vs Nuvation Bio
Over the past year SUPN returned −50.5% and NUVB returned −2.1%; their daily moves had a correlation of 0.16.
SUPN −50.5% NUVB −2.1%Growth of $1, one year, split-adjusted
| Metric | SUPN | NUVB |
|---|---|---|
| Price | $28.21 | $4.73 |
| Market cap | $1.64B | $1.66B |
| Today | +0.21% | +0.85% |
| 1 month | −34.1% | −3.1% |
| 6 months | −45.2% | −6.2% |
| Year to date | −43.2% | −47.2% |
| 1 year | — | −8.5% |
| Revenue growth (YoY) | +18.0% | +555.6% |
| Gross margin | 88.1% | 73.0% |
| Net margin | 9.2% | −198.3% |
| P/E (TTM) | — | — |
| Price / sales | 1.9× | 9.8× |
| Net cash | $359.5M | $399.4M |
| Dividend yield | 28.82% | — |
| Volatility (60d) | 86.1% | 50.8% |
| Short % of float | 7.3% | 23.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).